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major amputation rates are now increasing from those in
the mid 1980s.8
Recent actuarial statistics from the US Department of
Treasury estimate that in 1999 a person who was 80 years
of age can expect to live another 9.5 years, and a 90-year-
old person can expect to live an additional 5.0 years.9
Octogenarians are not only living longer but are socially
and physically more active. The purpose of our study was
to evaluate the long-term survival, graft patency, limb sal-
vage, and morbidity after an infrainguinal bypass graft in
octogenarians and septuagenarians and compare the mor-
tality and morbidity rates with octogenarians and septua-
genarians who did not require limb-salvaging procedures.
METHODS AND MATERIALS
We reviewed the charts of 1723 octogenarians and
2394 septuagenarians who were referred for possible vas-
cular disease between 1978 and 2000. Mild to moderate
atherosclerosis was present in 1514 octogenarian controls
who did not have severe lower extremity arterial occlusive
disease (ankle-brachial indices < 0.5 or flattened pulse vol-
ume recordings) and who did not require lower extremity
bypass procedures. Many of our control patients were ini-
tially referred for other conditions and had asymptomatic
small abdominal aortic aneurysms, hemodynamically sig-
nificant stenosis of cerebrovascular arteries, or chronic
venous disease. These patients underwent annual surveil-
lance, and some patients had studies performed without
cost to them to enable us to conduct our research. The
octogenarian controls were 83.6 ± 2.9 years of age at their
initial visit and were followed up for 4.8 ± 4.1 years.
Another 209 octogenarians had limb-threatening ischemia
and had 227 limb-salvage revascularizations. These
The US Census Bureau estimated that by January 1,
2000, there will be more than 25 million persons in the
United States who are older then 70 years, and 9.1 million
will be older than 80 years.1 Nearly 6% to 10% of elderly
persons will have intermittent claudication, and of these,
10% to 20% will be at risk for severe limb-threatening
ischemia, requiring revascularization or amputation.2
Severe atherosclerosis is a major contributor to death in
octogenarians and a cause of multiple vascular-related ail-
ments altering their quality of life.
Many older patients will have serious medical condi-
tions that can affect their recovery from operation, quality
of life, and survival. The benefit of lower extremity bypass
procedures may be limited in these patients. Advanced age
has been associated with an increased operative mortality
rate after most vascular operations.3 Limb-salvaging pro-
cedures have been denied to some patients because of
advanced age and poor health. Although it was suggested
more than a decade ago that advanced age should not be
considered a detriment for attempting distal revasculariza-
tions in these patients,4-7 a report, based on data from the
National Center for Health Statistics, has indicated that
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Infrainguinal revascularizations in octogenarians
and septuagenarians
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Objective: Severe atherosclerosis is a major contributor for death in octogenarians and a cause of multiple vascular-
related ailments, including claudication and limb loss. Advanced age and health may limit the success of limb-salvaging
procedures. Mortality, morbidity, and outcome of infrainguinal grafts have been examined in octogenarians and septu-
agenarians.
Methods: After 128 femoropopliteal and 99 femorotibial bypass grafts in 209 octogenarians and 242 femoropopliteal
and 166 femorotibial bypass grafts in 383 septuagenarians, survival, primary patency, limb salvage, myocardial infarc-
tion and stroke rates were determined. The survival, myocardial infarction, and stroke rates of controls, 1514 octoge-
narians and 2011 septuagenarians, were compared.
Results: After a bypass graft, 5-year survival of octogenarians (54%) and septuagenarians (64%) was similar (P > .2) and
was 89% and 89% for controls. The 5-year primary patency rates were 74% for octogenarians and 68% for septuage-
narians (P > .2). Five-year limb salvage rates were 86% for octogenarians and 86% for septuagenarians. After a bypass
graft, the respective rates of myocardial infarction were 4.1% and 3.9% per year and of a stroke 3.2% and 3.2% per year
for octogenarians and septuagenarians, which occurred more frequently (P < .05) than in controls.
Conclusions: Death and cardiovascular events are higher after revascularization in octogenarians and septuagenarians,
compared with controls, and are related to the severity of atherosclerosis and not age. Patency rates are excellent and
similar. Limb salvage procedures should be considered for most octogenarians. (J Vasc Surg 2001;34:133-8.)
patients were 84.2 ± 3.7 years of age at the time of their
revascularization and were followed up for 2.2 ± 2.2 years.
Another 45 patients were excluded from the study because
they had severe ischemia and no adequate runoff, requir-
ing above-the-ankle amputations. Mild to moderate ather-
osclerosis was also present in 2011 septuagenarian
controls who did not have severe lower extremity arterial
occlusive disease. These patients were 73.8 ± 3.0 years of
age at their initial visit and were followed up for 3.8 ± 3.9
years. Severe distal limb ischemia was present in 383 sep-
tuagenarians who had 408 distal revascularizations for
limb salvage. These patients were 74.7 ± 2.8 years of age
at the time of their surgery and were followed up for 3.0
± 3.1 years. Another 23 patients were excluded from the
study because they had severe ischemia and had no ade-
quate runoff, requiring above-the-ankle amputations.
The characteristics of the four patient groups were
determined to evaluate any differences among the groups
for prevalence of other severe diseases and risk factors that
might affect the outcome after distal revascularizations.
The incidence of severe coronary artery disease, angina,
chronic obstructive pulmonary disease, diabetes mellitus,
stroke, renal disease, hypertension, hypercholesterolemia,
and smoking cigarettes within the past 5 years was calcu-
lated and compared.
Over a 22-year span, 592 patients had infrainguinal
bypass grafts. Angiography was used to determine the
extent of the occlusion and the most suitable runoff vessel
or vessels for the distal anastomosis. Procedures were ini-
tial revascularizations for saving a limb and not for claudi-
cation. During the 11 years, 1978 to 1989, 196
septuagenarians had bypass grafts, 106 octogenarians had
bypass grafts, 623 septuagenarians became controls, and
574 octogenarians became controls. During the subse-
quent 11 years, 1989 to 2000, 187 septuagenarians had
bypass grafts, 103 octogenarians had bypass grafts, 1388
septuagenarians became controls, and 940 octogenarians
became controls. The greater saphenous vein was prefer-
entially used for the bypass grafts. When a suitable vein
segment was unavailable, polytetrafluoroethylene (PTFE)
grafts were then used for femoropopliteal bypass grafts. A
composite graft of a proximal PTFE segment combined to
a distal vein segment was the second choice for femorotib-
ial bypass grafts. When grafts were needed to bridge mul-
tiple occlusions, they were fashioned with sequential or
dual outflows (sequential grafts). Warfarin sodium was
prescribed to increase clotting time to 1.5 of the control
time in all cases where poor runoff was present and after
revascularizations with PTFE grafts and composite grafts.
Aspirin, 325 mg daily, was prescribed for all patients who
had autogenous vein grafts and at least two-vessel runoff.
Dipyridamole, 25 mg four times daily, was also prescribed.
Patients are routinely evaluated at the Long Island
Vascular Center, which is an independent, office-based
facility and is accredited by the Intersocietal Commission
for the Accreditation of Vascular Laboratories (ICAVL),
Columbia, Md. Most patients are referred by physicians,
patients, or family members. Nearly half of the patients
who have moved to distant locations return annually for
follow-up studies, and most of the other patients respond
to our inquiries about their health or have their family
physician or a family member inform us of their status.
Although most of our patients have been faithful to our
care, we have temporarily lost contact of approximately 5%
of our patients at 5 years. We actively attempt to obtain
current addresses and telephone numbers to enable us to
be aware of their current health conditions. Patients were
routinely seen annually from 1978 to 1987, and at 3, 6,
and 12 months and 1-year intervals from 1988 to the pre-
sent. At each visit, a detailed history for the symptoms of
claudication, rest pain, or ischemia was obtained, and
pedal pulses were determined. Segmental pressures and
pulse volume recordings were obtained at each visit by our
staff. Blood flow in the graft was measured with duplex
scanning when graft failing was suspected. A graft was
considered near occluded when the peak systolic velocity
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Table I. Patient characteristics by decade of age
70-80 70-80 80-90 80-90
bypass group control group bypass group control group 
No. % No. % No. % No. %
Men 220 57.4 1071 53.3 104 49.8 783 51.7
Angina 81 21.1 345 17.2 27 12.9* 218 14.4*
Coronary disease 160 41.8† 413 20.5 70 33.5† 276 8.2
Cancer 42 11.0 278 13.8 27 12.9 180 11.9
Chronic obstructive pulmonary disease 32 8.4† 70 3.5 18 8.6† 74 4.9
Stroke 62 16.2 265 13.2 28 13.4 179 11.8
Diabetes mellitus 182 47.5† 410 20.4 79 37.8*† 227 15.0*
Cholesterol 70 18.3 389 19.3 24 11.5† 275 18.2
Hypertension 159 41.5 917 45.6 77 36.8 520 34.3*
Renal disease 36 9.4 146 7.3 13 6.2 93 6.1
Smoker 197 51.4† 862 42.9 72 34.4* 576 38.0*
Total patients 383 100 2011 100 209 100 1514 100
*P value < .05 compared with age-related control.
†P value < .05 compared with bypass groups or control groups.
was less than 45 cm/s and the ankle-brachial index was
decreased by more than 0.15. All surveillance methods
have followed the established guidelines of the Inter-
societal Commission for the Accreditation of Vascular
Laboratories.
After patients were grouped according to their age at
the time of revascularization or for the control group, the
mean ages of the patients and SDs were calculated.
Statistical analyses were performed by TS with the True
Epistat program (Epistat Services, Richardson, Tex).
Cumulative life tables for primary and secondary graft
patency, limb salvage, and survival were determined with
the product-limit method of the Kaplan-Meier, and rates
were compared with the log-rank test. The Fisher exact
test was used to compare groups for the incidence of coex-
isting factors and for the occurrence of a myocardial
infarction or stroke. A statistical difference was inferred
with a P value of less than .05.
RESULTS
The characteristics of the patient groups are given in
Table I. There were no differences in the male/female
ratios and in the prevalence of cancer, stroke, and renal
disease among the groups. Among patients who had distal
revascularizations, octogenarians had a slightly lower inci-
dence of angina, diabetes mellitus, hypercholesterolemia,
and cigarette smoking than those septuagenarians with a
bypass graft, but the incidence of severe coronary artery
disease, chronic obstructive pulmonary disease, and hyper-
tension was the same in these two groups. When com-
pared with the age-related control group, patients who
had undergone bypass grafts had a higher incidence of
coronary disease, chronic obstructive pulmonary disease,
and diabetes mellitus. The septuagenarians who under-
went a bypass graft also had an increased incidence of
coronary disease, chronic obstructive pulmonary disease,
diabetes mellitus, and cigarette smoking. All octogenari-
ans had a lower incidence of angina, diabetes mellitus,
hypertension, and cigarette smoking than septuagenarians.
The age and sex of our patients and the graft type that
was used are given in Table II. In the octogenarians there
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were 128 femoropopliteal bypass grafts in 60 men and 62
women and 99 femorotibial bypass grafts in 53 men and
34 women. In the octogenarians, femoropopliteal grafts
were composed of an autogenous vein in 51% of cases, of
PTFE in 46% of the procedures, and of a composite in 3%
of these bypass grafts. For femorotibial grafts, the vein was
used in 82% of bypass grafts and a composite was used in
18% of procedures. In the septuagenarians there were 242
femoropopliteal bypass grafts in 130 men and 107 women
and 166 femorotibial bypass grafts in 95 men and 54
women. In septuagenarians, femoropopliteal grafts were
composed of an autogenous vein in 59% of the bypass
grafts, PTFE in 34% of procedures, and a composite in 7%
of bypass grafts. For femorotibial grafts, the vein was used
in 87% of bypass grafts and a composite was used in 13%
of these procedures. Sequential grafts were used for 19%
of the femoropopliteal bypass grafts and for 28% of the
femorotibial bypass grafts in septuagenarians, and for 6%
of the femoropopliteal bypass grafts and for 33% of the
femorotibial bypass grafts in octogenarians.
The respective perioperative rate and 6-month sur-
vival after revascularization were 97% and 96% for both
octogenarians and septuagenarians. The 1-, 5-, and 10-
year survival was 87%, 54%, and 31%, respectively, for
octogenarians (Table I, online only) and 90%, 64%, and
37% for the septuagenarians (Table II, online only; Fig
1). Survival of octogenarians and septuagenarians after
distal bypass graft procedures was similar (P > .2). In
controls, the respective 1-, 5-, and 10-year survival was
98%, 89%, and 73% for octogenarians (Table III, online
only) and 97%, 89%, and 75% for the septuagenarians
(Table IV, online only). When compared with the age-
related control, survival was lower (P < .0001) in both
bypass groups.
The rate of myocardial infarction after revasculariza-
tion was 3.9% per year for septuagenarians and 4.1% per
year for octogenarians but only 1.3% per year for control
septuagenarians and 1.1% per year for control octogenari-
ans (P < .025). Strokes occurred at a rate of 3.2% per year
for septuagenarians and 3.2% per year for octogenarians
after revascularization, and occurred at 1.0% per year for
Table II. Age, sex, and graft type by decade of age
70-80 80-90
Bypass type Fem-pop Fem-tib Fem-pop Fem-tib
Men/women 130/107 95/54 60/62 53/34
Autogenous vein 112 110 65 55
Sequential 32 34 0 26
Prosthetic (PTFE) 70 0 51 0
Sequential 12 0 8 0
Composite 13 9 4 11
Sequential 3 13 0 7
Total grafts 242 166 128 99
Graft type: sequential graft is a graft that had dual outflows to bridge multiple occlusions; composite graft is comprised of a proximal portion of PTFE anas-
tomosed to a distal portion of autogenous vein.
Fem-pop, Femoropopliteal; fem-tib, femorotibial; PTFE, polytetrafluoroethylene.
septuagenarian controls and 0.9% per year for octogenar-
ian controls (P < .05).
The primary patency rates of the grafts were similar (P
> .2) among octogenarians and septuagenarians (Fig 2).
The respective 1-, 5-, and 10-year rates were 79%, 74%,
and 71% for octogenarians (Table V, online only) and 83%,
68%, and 64% for septuagenarians (Table VI, online only).
The secondary rates were also similar; the 1-, 5-, and 10-
year rates were, respectively, 89%, 80%, and 80% for octo-
genarians (Table VII, online only) and 91%, 79%, and 72%
for septuagenarians (Table VIII, online only; Fig 3). Limb
salvage rates were also the same among these two groups,
and the 1-, 5-, and 10-year rates were, respectively, 90%,
86%, and 86% for octogenarians (Table IX, online only)
and 92%, 86%, and 86% for the septuagenarians (Table X,
online only; Fig 4).
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Fig 1. Cumulative life-table survival after femoropopliteal and
femorotibial bypass grafts in 209 octogenarians (80 BP) and 383
septuagenarians (70 BP) and of 1514 octogenarian controls (80
C) and 2011 septuagenarian controls who had mild-moderate
atherosclerosis and no revascularization. Survival in controls was
higher (P < .0001) compared with either bypass group, and sur-
vival among bypass groups was lower (P < .025) in octogenari-
ans. Number of patients at risk after bypass graft at beginning of
each time interval is shown; number for octogenarians is listed
below number for septuagenarians.
Fig 2. Cumulative life-table primary patency rates after
femoropopliteal and femorotibial bypass grafts in 227 limbs of
209 octogenarians (80 BP) and 408 limbs of 383 septuagenari-
ans (70 BP). Number of limbs at risk after bypass graft at begin-
ning of each time interval is shown; number for octogenarians is
listed below number for septuagenarians.
Fig 3. Cumulative life-table secondary patency rates after
femoropopliteal and femorotibial bypass grafts in 227 limbs of
209 octogenarians (80 BP) and 408 limbs of 383 septuagenari-
ans (70 BP). Number of limbs at risk after bypass graft at begin-
ning of each time interval is shown; number for octogenarians is
listed below number for septuagenarians.
Fig 4. Cumulative life-table limb salvage rates after
femoropopliteal and femorotibial bypass grafts in 227 limbs of
209 octogenarians (80 BP) and 408 limbs of 383 septuagenari-
ans (70 BP). Number of limbs at risk after bypass graft at begin-
ning of each time interval is shown; number for octogenarians is
listed below number for septuagenarians.
DISCUSSION
This study shows that most octogenarians can achieve
an excellent long-term outcome after infrainguinal revas-
cularization and supports the conclusions of shorter-term
studies of other investigators. The perioperative survival of
octogenarians and septuagenarians is similar. Among octo-
genarians, this reported survival after lower extremity
revascularization has varied from 93% to 100%3,5-7,10 and
agrees with our study (Table III). At 1 year, survival
declines and varies from 78% to 92%.5,6,7,10 Although our
1-year survival is similar to those from other investiga-
tors,5,6,7,10 our 3- and 5-year survival appears to be higher.
Much improvement in the medical management of these
patients has occurred in the past decade, and this has con-
tributed to the increased survival seen by us. Most of our
patients are followed up by a cardiologist, because approx-
imately a third of our patients have severe coronary artery
disease and myocardial infarction is still a significant cause
of death in our patients.
Our 1- and 3-year primary patency rates are similar to
those of other investigators (Table IV) whose rates vary
from 80% to 88% at 1 year and 56% to 62% at 3 years.5,6
Pomposelli et al10 have obtained a 5-year primary graft
patency rate of 72%, a secondary patency rate of 87%, and
a limb salvage rate of 92% in these older patients. In com-
parison, our 5-year primary and secondary graft patency
and limb salvage rates are 74%, 80%, and 86%, respec-
tively. These respective rates are similar to those in the
septuagenarians in this study and to those in a mixed-age
group reported by us earlier.11 Most investigators report
excellent limb salvage rates.5,7,10 Long-term anticoagula-
tion and antiplatelet therapy are important to improve
graft patency and are particularly necessary for patients
who are at a high risk for occlusion (eg, those with poor
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runoff, a prosthetic graft, a composite graft or a redo
bypass graft).12
Because elderly amputees have a significant risk for a
poor long-term survival,13 vascular surgeons need to be
innovative to find ways to bring increased blood flow to
ischemic regions and save limbs. After a major amputation,
the operative mortality rate varies from 12% to 23%,13 and
the median survival was only 1.4 years for women and 2.7
years for men. Survival among octogenarians was 45%,
11%, and 2% at 1, 5, and 10 years, respectively.14 Although
the 5-year survival after major amputation ranges from
11% to 40%,13-15 our 5-year survival after revascularization
is greater than 50%.
In our study septuagenarians had a higher prevalence
of some risk factors. The earlier development of peripheral
arterial disease in this group may be associated with these
factors and their genetic makeup. Patients who have
peripheral arterial disease later in life, the octogenarians,
may also have a slower progression of other atherosclerotic
diseases. The severity of comorbidity in octogenarians may
be less than in septuagenarians. 
Because excellent results from distal revascularization
of the lower extremity can be expected in elderly patients,
we think that bypass procedures need to be attempted
aggressively in these patients. A major amputation is only
considered if there is virtually no flow in the runoff vessels.
We gratefully acknowledge the assistance of Mrs
Connie Limoncelli for her diligence to collect and record
these data.
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